-
3
-
-
84871488770
-
-
Centers for Disease Control and Prevention, 2011. Available from, Accessed August 20,
-
Centers for Disease Control and Prevention. Device-associated events: VAP. 2011. Available from: http://www.cdc.gov/nhsn/PDFs/pscManual/6pscVAPcurrent.pdf. Accessed August 20, 2011.
-
(2011)
Device-associated events: VAP
-
-
-
5
-
-
0035029378
-
Biofilms and device-associated infections
-
Donlan RM. Biofilms and device-associated infections. Emerg Infect Dis. 2001;7:277-281.
-
(2001)
Emerg Infect Dis
, vol.7
, pp. 277-281
-
-
Donlan, R.M.1
-
6
-
-
0029024556
-
The pathogenesis of ventilator-associated pneumonia: I. Mechanisms of bacterial transcolonization and airway inoculation
-
Estes RJ, Meduri GU. The pathogenesis of ventilator-associated pneumonia: I. Mechanisms of bacterial transcolonization and airway inoculation. Intensive Care Med. 1995;21:365-383.
-
(1995)
Intensive Care Med
, vol.21
, pp. 365-383
-
-
Estes, R.J.1
Meduri, G.U.2
-
7
-
-
27244457431
-
The pathogenesis of ventilator-associated pneumonia: Its relevance to developing effective strategies for prevention
-
Safdar N, Crnich CJ, Maki DG. The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention. Respir Care. 2005;50:725-739.
-
(2005)
Respir Care
, vol.50
, pp. 725-739
-
-
Safdar, N.1
Crnich, C.J.2
Maki, D.G.3
-
9
-
-
0016221051
-
Aspiration pneumonia: Prevention of aspiration in patients with tracheostomies
-
Bone DK, Davis JL, Zuidema GD, Cameron JL. Aspiration pneumonia: prevention of aspiration in patients with tracheostomies. Ann Thorac Surg. 1974;18:30-37.
-
(1974)
Ann Thorac Surg
, vol.18
, pp. 30-37
-
-
Bone, D.K.1
Davis, J.L.2
Zuidema, G.D.3
Cameron, J.L.4
-
10
-
-
0018861582
-
Effects of endotracheal intubation on normal cough performance
-
Gal TJ. Effects of endotracheal intubation on normal cough performance. Anesthesiology. 1980;52:324-329.
-
(1980)
Anesthesiology
, vol.52
, pp. 324-329
-
-
Gal, T.J.1
-
11
-
-
46249086815
-
Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: Systematic review and meta-analysis of randomized, controlled trials
-
Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis. 2008;47:83-93.
-
(2008)
Clin Infect Dis
, vol.47
, pp. 83-93
-
-
Yahav, D.1
Rozen-Zvi, B.2
Gafter-Gvili, A.3
Leibovici, L.4
Gafter, U.5
Paul, M.6
-
12
-
-
0031808264
-
Tunneled hemodialysis catheters: Use of a silver-coated catheter for prevention of infection: A randomized study
-
Trerotola SO, Johnson MS, Shah H, etal. Tunneled hemodialysis catheters: use of a silver-coated catheter for prevention of infection: a randomized study. Radiology. 1998;207:491-496.
-
(1998)
Radiology
, vol.207
, pp. 491-496
-
-
Trerotola, S.O.1
Johnson, M.S.2
Shah, H.3
-
13
-
-
0030819751
-
Evaluation of chlorohexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: A randomized controlled trial
-
Logghe C, Van Ossel C, D'Hoore W, Ezzedine H, Wauters G, Haxhe JJ. Evaluation of chlorohexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. J Hosp Infect. 1997;37:145-156.
-
(1997)
J Hosp Infect
, vol.37
, pp. 145-156
-
-
Logghe, C.1
van Ossel, C.2
D'Hoore, W.3
Ezzedine, H.4
Wauters, G.5
Haxhe, J.J.6
-
14
-
-
33750096683
-
Silver in health care: Antimicrobial effects and safety in use
-
Lansdown AB. Silver in health care: antimicrobial effects and safety in use. Curr Probl Dermatol. 2006;33:17-34.
-
(2006)
Curr Probl Dermatol
, vol.33
, pp. 17-34
-
-
Lansdown, A.B.1
-
15
-
-
59449100491
-
Antibacterial action of selenium-enriched probiotics against pathogenic Escherichia coli
-
Yang J, Huang K, Qin S, Wu X, Zhao Z, Chen F. Antibacterial action of selenium-enriched probiotics against pathogenic Escherichia coli. Dig Dis Sci. 2009;54:246-254.
-
(2009)
Dig Dis Sci
, vol.54
, pp. 246-254
-
-
Yang, J.1
Huang, K.2
Qin, S.3
Wu, X.4
Zhao, Z.5
Chen, F.6
-
16
-
-
0037805206
-
Synthesis and antibacterial activity of organoselenium compounds
-
Ratushnaya EV, Kirova YI, Suchkov MA, Drevko BI, Borodulin VB. Synthesis and antibacterial activity of organoselenium compounds. Pharm Chem J. 2002;36:652-653. http://www.springerlink.com/content/l784168r2t302436/.
-
(2002)
Pharm Chem J
, vol.36
, pp. 652-653
-
-
Ratushnaya, E.V.1
Kirova, Y.I.2
Suchkov, M.A.3
Drevko, B.I.4
Borodulin, V.B.5
-
17
-
-
54349124541
-
New organoselenium compounds active against pathogenic bacteria, fungi and viruses
-
Pietka-Ottlik M, Wójtowicz-Młochowska H, Kołodziejczyk K, Piasecki E, Młochowski J. New organoselenium compounds active against pathogenic bacteria, fungi and viruses. Chem Pharm Bull. 2008;56:1423-1427.
-
(2008)
Chem Pharm Bull
, vol.56
, pp. 1423-1427
-
-
Pietka-Ottlik, M.1
Wójtowicz-Młochowska, H.2
Kołodziejczyk, K.3
Piasecki, E.4
Młochowski, J.5
-
19
-
-
0028332519
-
On the nature of selenium toxicity and carcinostatic activity
-
Spallholz JE. On the nature of selenium toxicity and carcinostatic activity. Free Radic Biol Med. 1994;17:45-64.
-
(1994)
Free Radic Biol Med
, vol.17
, pp. 45-64
-
-
Spallholz, J.E.1
-
20
-
-
67649147453
-
-
inventors, United States patent US 7205002. April 17,
-
Sieber F, Günther WHH, Daziano J-P, Krieg-Kowald M, Bousbaa J, Bula RJ, inventors. Method of making, and the use of cytotoxic agents containing elemental selenium. United States patent US 7205002. April 17, 2007.
-
(2007)
Method of making, and the use of cytotoxic agents containing elemental selenium
-
-
Sieber, F.1
Günther, W.H.H.2
Daziano, J.-P.3
Krieg-Kowald, M.4
Bousbaa, J.5
Bula, R.J.6
-
22
-
-
0034662094
-
The importance of selenium to human health
-
Rayman MP. The importance of selenium to human health. Lancet. 2000;356:233-241.
-
(2000)
Lancet
, vol.356
, pp. 233-241
-
-
Rayman, M.P.1
-
23
-
-
34247147993
-
Elemental selenium at nano size possesses lower toxicity without compromising the fundamental effect on selenoenzymes: Comparison with selenomethionine in mice
-
Wang H, Zhang J, Yu H. Elemental selenium at nano size possesses lower toxicity without compromising the fundamental effect on selenoenzymes: comparison with selenomethionine in mice. Free Radic Biol Med. 2007;42:1524-1533.
-
(2007)
Free Radic Biol Med
, vol.42
, pp. 1524-1533
-
-
Wang, H.1
Zhang, J.2
Yu, H.3
-
24
-
-
34548419783
-
Size effect of elemental selenium nanoparticles (Nano-Se) at supranutritional levels on selenium accumulation and glutathione S-transferase activity
-
Peng D, Zhang J, Liu Q, Taylor EW. Size effect of elemental selenium nanoparticles (Nano-Se) at supranutritional levels on selenium accumulation and glutathione S-transferase activity. J Inorg Biochem. 2007;101:1457-1463.
-
(2007)
J Inorg Biochem
, vol.101
, pp. 1457-1463
-
-
Peng, D.1
Zhang, J.2
Liu, Q.3
Taylor, E.W.4
-
25
-
-
35648929896
-
Comparativein vitro cytotoxicity assessment of selected gaseous compounds in human alveolar epithelial cells
-
Bakand S, Winder C, Hayes A. Comparativein vitro cytotoxicity assessment of selected gaseous compounds in human alveolar epithelial cells. Toxicol In Vitro. 2007;21:1341-1347.
-
(2007)
Toxicol In Vitro
, vol.21
, pp. 1341-1347
-
-
Bakand, S.1
Winder, C.2
Hayes, A.3
-
26
-
-
84856385247
-
Nanoparticles: A review of particle toxicology following inhalation exposure
-
Bakand S, Hayes A, Dechsakulthorn F. Nanoparticles: a review of particle toxicology following inhalation exposure. Inhal Toxicol. 2012;24:125-135.
-
(2012)
Inhal Toxicol
, vol.24
, pp. 125-135
-
-
Bakand, S.1
Hayes, A.2
Dechsakulthorn, F.3
-
27
-
-
1642556768
-
Inhibition of bacterial adhesion on PVC endotracheal tubes by RF-oxygen glow discharge, sodium hydroxide and silver nitrate treatments
-
Balazs DJ, Triandafillu K, Wood P, etal. Inhibition of bacterial adhesion on PVC endotracheal tubes by RF-oxygen glow discharge, sodium hydroxide and silver nitrate treatments. Biomaterials. 2004;25:2139-2151.
-
(2004)
Biomaterials
, vol.25
, pp. 2139-2151
-
-
Balazs, D.J.1
Triandafillu, K.2
Wood, P.3
|